H.-J. Sommerfeld
Papers
1
Total Citations
12
H-Index
1
About
H.-J. Sommerfeld is a leading urologic surgeon and clinical trialist whose work has fundamentally shaped the surgical management of kidney cancer. His primary research focus is the comparative effectiveness of minimally invasive versus open surgical techniques, with a particular emphasis on robotic-assisted partial nephrectomy (RAPN) for complex renal tumors. Sommerfeld’s most significant contribution is the landmark OpeRa trial, a prospective, randomized, open-label, multicenter study (NCT03849820) that directly compared RAPN to open partial nephrectomy (OPN) in patients with intermediate/high-complexity kidney tumors. The final results of this pivotal trial, published in 2025, have already garnered 12 citations, providing high-level evidence that is reshaping clinical guidelines and surgical decision-making. By rigorously evaluating 30-day postoperative complications, Sommerfeld has delivered crucial data that helps surgeons and patients weigh the benefits of robotic precision against the established outcomes of open surgery. His work stands as a model for evidence-based surgical innovation, directly impacting the standard of care for thousands of patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1